Narita Y, Masuyoshi S, Yamasaki T, Naito T, Kawaguchi H
Bristol-Myers Squibb Research Institute, Tokyo, Japan.
J Antibiot (Tokyo). 1991 Jan;44(1):86-92. doi: 10.7164/antibiotics.44.86.
The preparation and antibacterial activity of the 5''-guanidino (6) and 5''-amidino (7) derivatives of 4'-deoxybutirosin A (1) as well as the 5''-guanidino derivative (8) of butirosin A are described. The key intermediates, tetra-N-benzyloxycarbonyl-5''-azido derivatives were selectively reduced with NiCl2-NaBH4 to give the corresponding 5'-amino derivatives. Subsequent guanidination or amidination followed by deblocking afforded the final compounds 6, 7 and 8. The 5''-guanidino derivatives (6 and 8) were more active against Gram-positive and Gram-negative bacteria than the corresponding 5''-hydroxy derivatives (1 and butirosin A). Compound 6 was also active against a variety of methicillin-resistant Staphylococcus aureus (MRSA).
描述了4'-脱氧丁胺卡那霉素A(1)的5''-胍基(6)和5''-脒基(7)衍生物以及丁胺卡那霉素A的5''-胍基衍生物(8)的制备及其抗菌活性。关键中间体四-N-苄氧羰基-5''-叠氮基衍生物用NiCl₂-NaBH₄选择性还原,得到相应的5'-氨基衍生物。随后进行胍基化或脒基化,然后脱保护得到最终化合物6、7和8。5''-胍基衍生物(6和8)对革兰氏阳性菌和革兰氏阴性菌的活性比相应的5''-羟基衍生物(1和丁胺卡那霉素A)更高。化合物6对多种耐甲氧西林金黄色葡萄球菌(MRSA)也有活性。